Skip to content
2000
Volume 15, Issue 3
  • ISSN: 2210-3031
  • E-ISSN: 2210-304X

Abstract

Background

Oral fast-melting tablets (FMTs) have been gaining popularity due to their advantages in resolving swallowing issues of conventional oral tablets. Cocoa butter is an excipient of choice to develop FMT with an acceptable taste and faster onset of action of the drug.

Purpose

The present study aimed to prepare and characterize the amlodipine besylate-loaded cocoa butter FMTs.

Methods

Amlodipine besylate FMTs were prepared using a simple freezing (refrigeration) method. Cocoa butter (Form V) was used as the base to achieve a final tablet weight of 500 mg with drug and other functional excipients. The designed prototype tablet formulations were subjected to disintegration tests to determine the to determine the most robust batch. The formulation F4, containing 7% high-molecular-weight chitosan, exhibited the quickest disintegration time (DT) of 1.45 ± 0.10 min. Afterwards, the selected formulation, F4, was subjected to quality evaluation parameters.

Results

Fourier transform infrared spectroscopy (FTIR) studies revealed that there was no incompatibility between amlodipine besylate, cocoa butter, and other excipients. The average hardness of the F4 formulation tablet batch was found to be 2.69 ± 0.21 kg/cm2 and the friability was found to be 0.44%. The drug content in F4 tablets was found to be 102.38 ± 5.29% and showed an drug release of 94.30 ± 2.63% within 30 min. Over a six-month stability testing period, the chosen F4 formulation did not significantly change in terms of tablet average weight, disintegration time, drug content, and dissolution rate at 25°C ± 2°C/ 60% ± 5% relative humidity.

Conclusion

Selected formulation F4 with 7% of high molecular weight chitosan exhibited good physical properties, indicating the suitability of cocoa butter as a base to produce FMTs with the aid of a natural super-disintegrant.

Loading

Article metrics loading...

/content/journals/ddl/10.2174/0122103031299894240912092850
2024-09-23
2025-12-24
Loading full text...

Full text loading...

References

  1. BanoS. KumarS. SharmaP. TaleuzzamanM. Fast-Melt Tablets (FMTs): Revolutionizing rapid relief-an in-depth review of swift dissolve technology.Int. J. Biol. Pharmaceut. Sci. Arch.2023060200803610.53771/ijbpsa.2023.6.2.0087
    [Google Scholar]
  2. MaheshwariS. SinghA. VarshneyA.P. SharmaA. Advancing oral drug delivery: The science of fast dissolving tablets (FDTs).Intell. Pharm.20242458058710.1016/j.ipha.2024.01.011
    [Google Scholar]
  3. MasihA. KumarA. SinghS. TiwariA.K. Fast dissolving tablet: A review.Int. J. Curr. Pharm. Res.20179281810.22159/ijcpr.2017v9i2.17382
    [Google Scholar]
  4. KeanE.A. AdelekeO.A. Orally disintegrating drug carriers for paediatric pharmacotherapy.Eur. J. Pharm. Sci.202318210637710.1016/j.ejps.2023.10637736634740
    [Google Scholar]
  5. AroraP. SethiV.A. Orodispersible Tablets : A comprehensive review.Int. J. Res. Dev. Pharm. Life Sci.20132270284
    [Google Scholar]
  6. British PharmacopoeiaThe British Pharmacopoeia 2025.2025Available From: https://www.pharmacopoeia.com/
  7. ZulkifliN.A. Fashli Syafiq Abdul RazakL. The effect of disintegrants on the physical properties of a cocoa butter based fast melt tablet developed by a fusion moulding method.Int. J. Pharm. Excipients2019105561
    [Google Scholar]
  8. NguyenP.T.N. UlrichJ. Fast dispersible cocoa tablets: A case study of freeze-casting applied to foods.Chem. Eng. Technol.20143781376138210.1002/ceat.201400032
    [Google Scholar]
  9. Zhi QingP.C. JanakiramanA.K. RahmanS.A.K.M.E.H. Kai BinL. An overview of cocoa butter: Novel excipients for oral tablets.Int. J. Pharmaceut. Res.202113110.31838/ijpr/2021.13.01.373
    [Google Scholar]
  10. RothK. Chocolate – The noblest polymorphism III.ChemViews20103941642810.1002/chemv.201000031
    [Google Scholar]
  11. LiewK.B. MingL.C. GohB.H. PehK.K. Fast melt cocoa butter tablet: Effect of waxes, starch, and PEG 6000 on physical properties of the preparation.Molecules20222710312810.3390/molecules2710312835630605
    [Google Scholar]
  12. BulsaraK.G. PatelP. CassagnolM. Amlodipine.Treasure Island, FLStatPearls2024
    [Google Scholar]
  13. NovacM. MusucA.M. OzonE.A. SarbuI. MituM.A. RusuA. PetrescuS. AtkinsonI. GheorgheD. LupuliasaD. Design and evaluation of orally dispersible tablets containing amlodipine inclusion complexes in hydroxypropyl-β-cyclodextrin and methyl-β-cyclodextrin.Materials20221515521710.3390/ma15155217
    [Google Scholar]
  14. SinghD. TyagiV.K. PathakK. Semisolid matrix-filled hard gelatin capsules for rapid dissolution of amlodipine besilate: Development and assessment.J. Adv. Pharm. Technol. Res.201341424910.4103/2231‑4040.10749923662281
    [Google Scholar]
  15. AyorindeJ. OdeniyiM. Balogun-AgbajeO. Formulation and evaluation of oral dissolving films of amlodipine besylate using blends of starches with hydroxypropyl methyl cellulose.Polim. Med.2016461455110.17219/pim/6509828397418
    [Google Scholar]
  16. JangD.J. SimT. OhE. Formulation and optimization of spray- dried amlodipine solid dispersion for enhanced oral absorption.Drug Dev. Ind. Pharm.20133971133114110.3109/03639045.2012.72321823009032
    [Google Scholar]
  17. PareA. Formulation and evaluation of effervescent floating tablet of amlodipine besylate.Res. J. Pharm. Technol.200814879771
    [Google Scholar]
  18. KhanM.F.S. TahirL. ZhouX. BaryG. SajidM. ShahzadA.K. KhanI. MohamedA. AhmadR. Method development for simultaneous estimation of Amlodipine Besylate and Perindopril Tertbutyl amine in fixed-dose.Heliyon202393e1420910.1016/j.heliyon.2023.e1420936923897
    [Google Scholar]
  19. BadwarM.R. BorseS.L. JunagadeM.S. JadhavA.G. Formulation and evaluation of mouth dissolving tablet of amlodipine besylate.Int. J. Appl. Pharmaceut.20191113213910.22159/ijap.2019v11i4.31288
    [Google Scholar]
  20. Deep KaurC. PatelL. GuptaA. Deep KaurC. Ultra-violet spectrophotometric method for estimation and validation of amlodipine in bulk and tablet formulation.J. Anal. Pharm. Res.20174611310.15406/japlr.2017.04.00125
    [Google Scholar]
  21. JanakiramanA.K. SumathiB. Mohamed SaleemT. RamkanthS. Odaya KumarP. VenkatachalamG. Design and evaluation of Carvedilol nanocrystals sustained release tablets.J. Appl. Pharm. Sci.20177616810.7324/JAPS.2017.70408
    [Google Scholar]
  22. ChenJ. GhazaniS.M. StobbsJ.A. MarangoniA.G. Tempering of cocoa butter and chocolate using minor lipidic components.Nat. Commun.2021121501810.1038/s41467‑021‑25206‑134465789
    [Google Scholar]
  23. SonwaiS. RousseauD. Structure evolution and bloom formation in tempered cocoa butter during long-term storage.Eur. J. Lipid Sci. Technol.2006108973574510.1002/ejlt.200600078
    [Google Scholar]
  24. LonchamptP. HartelR.W. Surface bloom on improperly tempered chocolate.Eur. J. Lipid Sci. Technol.2006108215916810.1002/ejlt.200500260
    [Google Scholar]
  25. SmithK. Ingredient Preparation: The Science of Tempering.Science and Technology of Enrobed and Filled Chocolate, Confectionery and Bakery ProductsSawston, United KingdomWoodhead Publishing200931334310.1533/9781845696436.3.313
    [Google Scholar]
  26. JanakiramanA.K. YapJ. SundarapandianR. LiewK.B. SubramaniyanV. KayarohanamS. Fabrication and characterization of cocoa butter-based caffeine fast-melting tablets.Ther. Deliv.202411110.1080/20415990.2024.235411538888592
    [Google Scholar]
  27. YassinS. GoodwinD.J. AndersonA. SibikJ. Ian WilsonD. GladdenL.F. Axel ZeitlerJ. The Disintegration Process in Microcrystalline Cellulose Based Tablets, Part 1: Influence of Temperature, Porosity and Superdisintegrants.J. Pharm. Sci.2015104103440345010.1002/jps.24544
    [Google Scholar]
  28. RemyaK.S. BeenaP. BijeshP.V. SheebaA. Formulation development, evaluation and comparative study of effects of super disintegrants in cefixime oral disintegrating tablets.J. Young Pharm.20102323423910.4103/0975‑1483.6679421042477
    [Google Scholar]
  29. SunilR. MounikaK. VenkateshamA. Design and Fabrication of Medicated Chocolate Formulation by Chocolate Drug Delivery System.Int. J. Curr. Pharm. Res.2017912813310.22159/ijcpr.2017v9i5.22156
    [Google Scholar]
  30. United States Pharmacopeia(2091) Weight Variation of Dietary Supplements.2023Available From: https://doi.usp.org/USPNF/USPNF_M99985_02_01.html
  31. United States Pharmacopeia(1217) Tablet Breaking Force.2023Available From: https://doi.usp.org/USPNF/USPNF_M99937_02_01.html
  32. United States Pharmacopeia(1216) Tablet Friability.2023Available From: https://www.drugfuture.com/Pharmacopoeia/usp35/PDF/0867-0868%20%5B1216%5D%20TABLET%20FRIABILITY.pdf
  33. United States PharmacopeiaAmlodipine Besylate Tablets.2023Available From: https://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/amlodipineBesylateTabletsm3575.pdf
  34. United States Pharmacopeia(701) DISINTEGRATION.2023Available From: https://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/generalChapter701.pdf
  35. BaligaS. MuglikarS. KaleR. Salivary pH: A diagnostic biomarker.J. Indian Soc. Periodontol.201317446146510.4103/0972‑124X.11831724174725
    [Google Scholar]
  36. United States Pharmacopeia(711) Dissolution.2023Available From: https://www.usp.org/sites/default/files/usp/document/harmonization/gen-method/stage_6_monograph_25_feb_2011.pdf
    [Google Scholar]
  37. United States Food and Drug AdministrationDissolution testing and acceptance criteria for immediate-release solid oral dosage form drug products containing high solubility drug substances guidance for industry.2018Available From: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm
  38. WikipediaInternational Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.2003Available From: https://en.wikipedia.org/wiki/International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use
  39. BajajS. SakhujaN. SinglaD. Stability testing of pharmaceutical products.J. Appl. Pharm. Sci.20122129138
    [Google Scholar]
  40. González-GonzálezO. RamirezI.O. RamirezB.I. O’ConnellP. BallesterosM.P. TorradoJ.J. SerranoD.R. Drug stability: ICH versus accelerated predictive stability studies.Pharmaceutics20221411232410.3390/pharmaceutics1411232436365143
    [Google Scholar]
  41. NadafR.D. Sudhahar DharmalingaS.H. Stability indicating assay method development and validation of amlodipine besylate in bulk and tablet dosage form by UV Spectroscopy and RP-HPLC.J. Chem. Health Risks20231313971404
    [Google Scholar]
  42. WankhedeS.B. WadkarS.B. RakaK.C. ChitlangeS.S. Simultaneous estimation of amlodipine besilate and olmesartan medoxomil in pharmaceutical dosage form.Indian J. Pharm. Sci.200971556356710.4103/0250‑474X.5819020502580
    [Google Scholar]
  43. United States PharmacopeiaAmlodipine Besylate.2023Available From: https://doi.usp.org/USPNF/USPNF_M3570_05_01.html
  44. ChemanY. SyaharizaZ.A. MirghaniM.E.S. JinapS. BakarJ. Analysis of potential lard adulteration in chocolate and chocolate products using Fourier transform infrared spectroscopy.Food Chem.200590481581910.1016/j.foodchem.2004.05.029
    [Google Scholar]
  45. GoodacreR. AnklamE. Fourier transform infrared spectroscopy and chemometrics as a tool for the rapid detection of other vegetable fats mixed in cocoa butter.J. Am. Oil Chem. Soc.20017810993100010.1007/s11746‑001‑0377‑x
    [Google Scholar]
  46. AlakaylehF. RashidI. Al-OmariM.M.H. Al-Sou’odK. ChowdhryB.Z. BadwanA.A. Compression profiles of different molecular weight chitosans.Powder Technol.201629910711810.1016/j.powtec.2016.05.019
    [Google Scholar]
  47. HuanbuttaK. CheewatanakornkoolK. TeradaK. NunthanidJ. SriamornsakP. Impact of salt form and molecular weight of chitosan on swelling and drug release from chitosan matrix tablets.Carbohydr. Polym.2013971263310.1016/j.carbpol.2013.04.07323769512
    [Google Scholar]
  48. OlorunsolaE.O. AkpanG.A. AdikwuM.U. Evaluation of chitosan-microcrystalline cellulose blends as direct compression excipients.J Drug Deliv.20172017856385810.1155/2017/8563858
    [Google Scholar]
  49. DhakalB. ThakurJ.K. MahatoR.K. RawatI. RabinD.C. ChhetriR.R. ShahK.P. AdhikariA. PandeyJ. Formulation of ebastine fast-disintegrating tablet using coprocessed superdisintegrants and evaluation of quality control parameters.ScientificWorldJournal2022202211310.1155/2022/961834435645632
    [Google Scholar]
  50. HaradaT. NarazakiR. OhwakiT. UchidaT. Effect of physical properties of orally disintegrating tablets on disintegration time as determined by a new apparatus.J. Drug Deliv. Sci. Technol.201020537738310.1016/S1773‑2247(10)50062‑5
    [Google Scholar]
  51. PatelD.M. PatelD. ShahS. ShahA. Formulation and evaluation of fast dissolving tablets of nebivolol and valsartan.Int. J. Pharm. Sci. Res.2020111110.13040/IJPSR.0975‑8232.11(11).5530‑39
    [Google Scholar]
  52. SukhavasiS. KishoreV.S. Formulation and evaluation of fast dissolving tablets of amlodipine besylate by using Fenugreek seed mucilage and Ocimum basilicum gum.Int. Curr. Pharm. J.20121924324910.3329/icpj.v1i9.11614
    [Google Scholar]
  53. BharathiA. RamakrishnaV. SowjanyaK. Shobha DeepthiK. Formulation development and in-vitro evaluation of orally disintegrating tablets of amlodipine besylate.Int. J. Res. Pharm. Chem.2012210291034
    [Google Scholar]
  54. Raj. B.s. PunithaI.S.R. DubeS. Formulation and characterization of fast disintegrating tablets of amlodipine using super-disintegrants.J. Appl. Pharm. Sci.2012211812310.7324/JAPS.2012.2819
    [Google Scholar]
  55. GandhiL. AkhtarS. Comparative study on effect of natural and synthetic superdisintegrants in the formulation of orodispersible tablets.J. Drug Deliv. Ther.20199250751310.22270/jddt.v9i2.2404
    [Google Scholar]
  56. BasuB. BagadiyaA. MakwanaS. VipulV. BattD. DharamsiA. Formulation and evaluation of fast dissolving tablets of cinnarizine using superdisintegrant blends and subliming material.J. Adv. Pharm. Technol. Res.20112426627310.4103/2231‑4040.9088522247895
    [Google Scholar]
  57. MarklD. ZeitlerJ.A. A review of disintegration mechanisms and measurement techniques.Pharm. Res.201734589091710.1007/s11095‑017‑2129‑z28251425
    [Google Scholar]
  58. Swetha Arumilli Prasanthi Pakalapati PakalapatiP. SarellaP.N.K. Exploring the super-disintegrating properties of fenugreek seed mucilage for fast-dissolving amlodipine tablets.World J. Biol. Pharm. Health Sci.202316118619710.30574/wjbphs.2023.16.1.0438
    [Google Scholar]
  59. DraksieneG. VenclovaiteB. PudziuvelyteL. IvanauskasL. MarksaM. BernatonieneJ. Natural polymer chitosan as super disintegrant in fast orally disintegrating meloxicam tablets: Formulation and evaluation.Pharmaceutics202113687910.3390/pharmaceutics1306087934203634
    [Google Scholar]
  60. PatelD. PatelS. PatelC. Formulation and evaluation of fast dissolving tablet containing domperidone ternary solid dispersion.Int. J. Pharm. Investig.20144417418210.4103/2230‑973X.14311625426438
    [Google Scholar]
/content/journals/ddl/10.2174/0122103031299894240912092850
Loading
/content/journals/ddl/10.2174/0122103031299894240912092850
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test